AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Rxsight Inc (NASDAQ:RXST)
14.455 USD
-0.535 3.569%Sponsored Reports
Loading...
| Previous Close (in USD) | 14.99 |
|---|---|
| Change | -0.535 3.569% |
| 52 W H/L (in USD) | 66.540/20.660 |
| EBITDA (in USD) | -43.42M |
| PE Ratio | -- |
| Volume | 601415 |
| Diluted Eps TTM | -1.24 |
| Total Assets (in USD) | 182.55M |
|---|---|
| Total Liabilities (in USD) | 22.188M |
| Revenue TTM (in USD) | 101.1M |
| Cash (in USD) | 9.692M |
| Market Cap (in USD) | 2,443.699 M |
| Revenue Per Share TTM | 2.827 |
| Gross Profit TTM (in USD) | 21.328M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Rxsight Inc
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Employees: 374
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Dr. Ronald M. Kurtz M.D. | Pres, CEO & Director | 1963 |
| 2. | Ms. Shelley B. Thunen | CFO & Assistant Sec. | 1954 |
| 3. | Dr. Ilya Goldshleger Ph.D. | Chief Operating Officer | 1975 |
| 4. | Mr. Eric J. Weinberg | Chief Commercial Officer | 1961 |
| 5. | Rebecca Williston | VP of Accounting & Fin. | NA |
| 6. | Mr. Matt Haller Ph.D. | Chief Technology Officer | NA |
| 7. | Steve Everly | VP of US Sales | NA |
| 8. | Mr. Roy Freeman | VP of Marketing | NA |
| 9. | Caroline Vaughn | VP of HR | NA |
| 10. | Scott Gaines | Sr. VP of Commercial Operations & Bus. Process | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
-1.310 1.057% | 121.625 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
|
SYK
Stryker Corporation |
-2.800 0.830% | 335 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
-1.130 1.380% | 80.5 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
-2.295 2.532% | 90.22 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Income Before Tax | -66.747M | -48.68M | 27.632M | 126.244M |
| Minority Interest | - | - | - | - |
| Net Income | -66.756M | -48.688M | 27.575M | 126.22M |
| Selling General Administrative | 58.665M | 32.805M | 15.176M | 15.203M |
| Gross Profit | 21.328M | 4.517M | 1.705M | -1.819M |
| Reconciled Depreciation | 4.022M | 3.988M | 4.012M | 3.93M |
| Ebit | -63.318M | -52.787M | -35.405M | -46.07M |
| Ebitda | -61.801M | -52.733M | -30.85M | -40.354M |
| Depreciation And Amortization | 1.517M | 0.054M | 4.555M | 5.716M |
| Operating Income | -63.318M | -52.787M | -35.405M | -46.07M |
| Other Operating Expenses | 112.323M | 75.38M | 50.083M | 48.832M |
| Interest Expense | 4.946M | 3.682M | 0.51M | 0.026M |
| Tax Provision | 0.009M | 0.008M | 0.057M | 0.024M |
| Interest Income | 1.517M | 0.054M | 0.543M | 2.307M |
| Net Interest Income | -3.429M | -3.628M | 0.033M | 2.281M |
| Income Tax Expense | 0.009M | 0.008M | 0.057M | 0.024M |
| Total Revenue | 49.005M | 22.593M | 14.678M | 2.241M |
| Total Operating Expenses | 84.646M | 57.304M | 37.11M | 44.772M |
| Cost Of Revenue | 27.677M | 18.076M | 12.973M | 4.06M |
| Total Other Income Expense Net | -3.429M | 4.107M | 63.037M | 172.314M |
| Net Income From Continuing Ops | -66.756M | -48.688M | 27.575M | 126.22M |
| Net Income Applicable To Common Shares | -66.756M | -48.688M | 3.366M | 26.127M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 182.55M | 150.164M | 192.721M | 100.677M | 110.432M |
| Intangible Assets | - | - | - | - | - |
| Other Current Assets | 3.523M | 2.962M | 4.069M | 1.372M | 1.523M |
| Total Liab | 22.188M | 60.262M | 54.479M | 398.206M | 415.043M |
| Total Stockholder Equity | 160.362M | 89.902M | 138.242M | -297.529M | -304.611M |
| Other Current Liab | 13.194M | 11.324M | 7.241M | 8.754M | 4.89M |
| Common Stock | 0.036M | 0.028M | 0.027M | 80.78M | 56.422M |
| Capital Stock | 0.036M | 0.028M | 0.027M | 80.78M | 56.422M |
| Retained Earnings | -594.64M | -546.032M | -479.276M | -430.588M | -419.855M |
| Good Will | - | - | - | - | - |
| Other Assets | - | 1.528M | 0.925M | 0.571M | 0.983M |
| Cash | 9.692M | 11.834M | 24.361M | 13.994M | 7.958M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 20.903M | 17.237M | 11.077M | 11.6M | 8.457M |
| Current Deferred Revenue | 2.045M | 1.348M | 0.618M | 0.438M | 0.378M |
| Net Debt | -6.68M | 33.161M | 20.57M | 16.758M | -2.442M |
| Short Term Debt | 1.801M | 1.97M | 1.529M | 1.274M | 0.99M |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 3.012M | 44.995M | 44.931M | 30.752M | 5.516M |
| Other Stockholder Equity | 754.971M | 636.001M | 424.79M | 52.282M | 58.776M |
| Property Plant Equipment | - | 10.138M | 11.217M | 18.606M | 19.25M |
| Total Current Assets | 168.407M | 134.555M | 176.295M | 81.5M | 90.199M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | 117.49M | 93.968M | 134.971M | 54.981M | 72.71M |
| Net Receivables | 20.281M | 10.956M | 4.862M | 2.865M | 0.789M |
| Long Term Debt | - | 40.169M | 43.402M | 24.399M | - |
| Inventory | 17.421M | 14.835M | 8.032M | 8.288M | 7.219M |
| Accounts Payable | 3.863M | 2.595M | 1.689M | 1.134M | 2.199M |
| Accumulated Other Comprehensive Income | -0.005M | -0.095M | -0.02M | -0.003M | 0.046M |
| Non Currrent Assets Other | 0.147M | 1.528M | 0.925M | 0.571M | 0.983M |
| Non Current Assets Total | 14.143M | 15.609M | 16.426M | 19.177M | 20.233M |
| Capital Lease Obligations | 3.012M | 4.826M | 5.171M | 6.353M | 5.516M |
| Long Term Debt Total | - | - | 43.402M | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Investments | 42.343M | -79.967M | 18.127M | -2.387M |
| Total Cashflows From Investing Activities | 39.95M | -81.907M | 15.591M | -5.87M |
| Total Cash From Financing Activities | 6.332M | 137.342M | 25.237M | 1.33M |
| Net Income | -66.756M | -48.688M | 27.575M | 126.22M |
| Change In Cash | -12.577M | 10.717M | 5.625M | -45.154M |
| Begin Period Cash Flow | 25.172M | 14.455M | 8.83M | 53.984M |
| End Period Cash Flow | 12.595M | 25.172M | 14.455M | 8.83M |
| Total Cash From Operating Activities | -58.85M | -44.708M | -35.203M | -40.619M |
| Depreciation | 4.022M | 3.988M | 4.012M | 3.93M |
| Other Cashflows From Investing Activities | - | - | - | - |
| Dividends Paid | - | - | - | - |
| Change To Inventory | -7.555M | -2.111M | -1.307M | -5.471M |
| Sale Purchase Of Stock | -0.587M | 121.926M | - | - |
| Other Cashflows From Financing Activities | 0.403M | 17.787M | 25.379M | 1.515M |
| Capital Expenditures | 2.393M | 1.94M | 2.539M | 4.086M |
| Change In Working Capital | -7.412M | -2.678M | -7.848M | -3.971M |
| Other Non Cash Items | -0.101M | 0.493M | 0.085M | -171.396M |
| Free Cash Flow | -61.243M | -46.648M | -37.742M | -44.705M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Artisan International Small-Mid Investor | 1 year ago | 1187207 |
| 2. | Artisan Non-U.S. Small-Mid Growth Comp | 1 year ago | 1187207 |
| 3. | Lord Abbett Developing Growth A | 1 year ago | 973748 |
| 4. | Vanguard Total Stock Mkt Idx Inv | 11 months ago | 848486 |
| 5. | iShares Russell 2000 ETF | 11 months ago | 663719 |
| 6. | Xtrackers MSCI World Swap ETF 1C | 11 months ago | 568920 |
| 7. | Fidelity Small Cap Growth | 1 year ago | 486942 |
| 8. | Invesco OFI Small Cap Growth | 1 year ago | 459946 |
| 9. | Invesco Discovery A | 1 year ago | 459946 |
| 10. | Vanguard Institutional Extnd Mkt Idx Tr | 11 months ago | 342648 |
| 11. | Fidelity Small Cap Index | 1 year ago | 291012 |
| 12. | Old Westbury Small & Mid Cap Strategies | 1 year ago | 283219 |
| 13. | CREF Stock R1 | 1 year ago | 275390 |
| 14. | T. Rowe Price Small-Cap Stock | 1 year ago | 263453 |
| 15. | T. Rowe Price US Small-Cap Core Equity | 1 year ago | 263453 |
| 16. | iShares Russell 2000 Growth ETF | 11 months ago | 240200 |
| 17. | Nuveen Quant Small Cap Equity R6 | 1 year ago | 225230 |
| 18. | Federated Hermes MDT SCC Institutional | 1 year ago | 212904 |
| 19. | Federated Hermes MDT Small Cap Core IS | 1 year ago | 212904 |
| 20. | Fidelity Small Cap Growth K6 | 1 year ago | 180708 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | RA Capital Management, LLC | 1 year ago | 3404285 |
| 2. | BlackRock Inc | 1 year ago | 2076470 |
| 3. | Artisan Partners Limited Partnership | 1 year ago | 1895741 |
| 4. | Lord, Abbett & Co LLC | 1 year ago | 1772390 |
| 5. | Vanguard Group Inc | 1 year ago | 1524510 |
| 6. | FMR Inc | 1 year ago | 1186477 |
| 7. | Morgan Stanley - Brokerage Accounts | 1 year ago | 1073062 |
| 8. | SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1 year ago | 783069 |
| 9. | T. Rowe Price Investment Management,Inc. | 1 year ago | 772219 |
| 10. | Deutsche Bank AG | 1 year ago | 706394 |
| 11. | State Street Corporation | 1 year ago | 703967 |
| 12. | Nuveen Asset Management, LLC | 1 year ago | 695705 |
| 13. | JPMorgan Chase & Co | 1 year ago | 596540 |
| 14. | Geode Capital Management, LLC | 1 year ago | 558507 |
| 15. | Bank of America Corp | 1 year ago | 538550 |
| 16. | Next Century Growth Investors LLC | 1 year ago | 510513 |
| 17. | Gilder Gagnon Howe & CO LLC | 1 year ago | 458525 |
| 18. | Atika Capital Management LLC | 1 year ago | 444000 |
| 19. | Parkman Healthcare Partners LLC | 1 year ago | 412432 |
| 20. | Driehaus Capital Management LLC | 1 year ago | 403795 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...
